Edluar and Abilify drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 13 people who take Edluar and Abilify. Common interactions include pain among females.

The phase IV clinical study analyzes what interactions people who take Edluar and Abilify have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

13 people who take Edluar and Abilify together, and have interactions are studied.

What is Edluar?

Edluar has active ingredients of zolpidem tartrate. It is used in insomnia. Currently, eHealthMe is studying from 150 Edluar users.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is used in depression. Currently, eHealthMe is studying from 98,584 Abilify users.

Number of Edluar and Abilify reports submitted per year:

Edluar and Abilify drug interactions.

Common Edluar and Abilify drug interactions by gender *:


  1. Pain
  2. Weight decreased
  3. Eating disorder
  4. Fracture
  5. Hip arthroplasty
  6. Hospitalisation
  7. Memory impairment
  8. Post procedural complication
  9. Restless legs syndrome
  10. Retching



Common Edluar and Abilify drug interactions by age *:














  1. Hypersensitivity
  2. Rash pruritic
  3. Abdominal pain upper
  4. Diarrhoea
  5. Drug hypersensitivity
  6. Eating disorder
  7. Post procedural complication
  8. Restless legs syndrome
  9. Viral infection


  1. Hip arthroplasty

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 92.31%
  2. Drowsiness: 2 people, 15.38%
  3. Viral Infection: 1 person, 7.69%
  4. Sleep Disorder: 1 person, 7.69%
  5. Neuritis (inflammation of nerve): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Edluar and Abilify?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Abilify side effects:

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Abilify interactions:

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and aripiprazole (the active ingredients of Edluar and Abilify, respectively), and Edluar and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Edluar and Abilify.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: